Todd M. Bauer
Impact in
- Oncology top 0.2%
- Cancer Immunotherapy and Biomarkers
- Lung Cancer Research Studies
- HER2/EGFR in Cancer Research
- CAR-T cell therapy research
- Pulmonary and Respiratory Medicine top 0.2%
- Lung Cancer Treatments and Mutations
Papers in
- Oncology 154
- Cancer Immunotherapy and Biomarkers 46
- Lung Cancer Research Studies 25
- Colorectal Cancer Treatments and Studies 24
- CAR-T cell therapy research 23
-
- Lung Cancer Treatments and Mutations 71
- Renal cell carcinoma treatment 23
- Co-authors
- Alice T. Shaw (40 shared papers)Benjamin Solomon (41 shared papers)Enriqueta Felip (34 shared papers)Holger Thurm (21 shared papers)Manish R. Patel (34 shared papers)Gerson Peltz (11 shared papers)Benjamin Besse (23 shared papers)Antonello Abbattista (17 shared papers)
- Journals
- Journal of Clinical Oncology (106 papers)Annals of Oncology (37 papers)Cancer Research (18 papers)Journal of Thoracic Oncology (13 papers)Clinical Cancer Research (10 papers)
- Partner nations
- United StatesFranceItaly
In The Last Decade
Todd M. Bauer
255 papers receiving 8.8k citations
Todd M. Bauer's Hit Papers
Peers
Comparison fields: 5 of 114
- Oncology 4.6k
- Pulmonary and Respiratory Medicine 3.9k
- Cancer Research 1.2k
- Biological Psychiatry 205
- Immunology 1.3k
Countries citing papers authored by Todd M. Bauer
This map shows the geographic impact of Todd M. Bauer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Todd M. Bauer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Todd M. Bauer more than expected).
Fields of papers citing papers by Todd M. Bauer
This network shows the impact of papers produced by Todd M. Bauer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Todd M. Bauer. The network helps show where Todd M. Bauer may publish in the future.
Co-authors
The 25 scholars most cited alongside Todd M. Bauer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 265 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | First-Line Lorlatinib or Crizotinib in Advanced ALK -Positive Lung Cancer Hit paper breakdown → | 2020 | 683 |
| 2 | Lorlatinib in non-small-cell lung cancer with ALK or ROS1 rearrangement: an international, multicentre, open-label, single-arm first-in-man phase 1 trial Hit paper breakdown → | 2017 | 506 |
| 3 | 2018 | 317 | |
| 4 | 2019 | 279 | |
| 5 | Lorlatinib in advanced ROS1-positive non-small-cell lung cancer: a multicentre, open-label, single-arm, phase 1–2 trial Hit paper breakdown → | 2019 | 261 |
| 6 | First-in-human phase 1 study of the anti-TIGIT antibody vibostolimab as monotherapy or with pembrolizumab for advanced solid tumors, including non-small-cell lung cancer☆ Hit paper breakdown → | 2021 | 209 |
| 7 | 2017 | 182 | |
| 8 | 2016 | 179 | |
| 9 | 2015 | 179 | |
| 10 | 2017 | 178 | |
| 11 | 2016 | 150 | |
| 12 | 2018 | 148 | |
| 13 | Efficacy and safety of first-line lorlatinib versus crizotinib in patients with advanced, ALK-positive non-small-cell lung cancer: updated analysis of data from the phase 3, randomised, open-label CROWN study Hit paper breakdown → | 2022 | 138 |
| 14 | Lorlatinib Versus Crizotinib in Patients With Advanced ALK -Positive Non–Small Cell Lung Cancer: 5-Year Outcomes From the Phase III CROWN Study Hit paper breakdown → | 2024 | 132 |
| 15 | 2016 | 129 | |
| 16 | 2014 | 127 | |
| 17 | 2017 | 119 | |
| 18 | 2021 | 119 | |
| 19 | 2019 | 118 | |
| 20 | 2019 | 118 |
About Todd M. Bauer
Todd M. Bauer is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Molecular Biology, Cancer Research and Immunology, having authored 265 papers that have together received 9.0k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (71 papers), Cancer Immunotherapy and Biomarkers (46 papers), Cancer Genomics and Diagnostics (29 papers), Lung Cancer Research Studies (25 papers), Colorectal Cancer Treatments and Studies (24 papers), Renal cell carcinoma treatment (23 papers), CAR-T cell therapy research (23 papers) and Cancer Research and Treatments (22 papers). The work is most often cited by research in Oncology (4.6k citations), Pulmonary and Respiratory Medicine (3.9k citations), Cancer Research (1.2k citations), Biological Psychiatry (205 citations) and Immunology (1.3k citations). Todd M. Bauer has collaborated with scholars based in United States, France and Italy. Frequent co-authors include Alice T. Shaw, Benjamin Solomon, Enriqueta Felip, Holger Thurm, Manish R. Patel, Gerson Peltz, Benjamin Besse, Antonello Abbattista, Jeffrey R. Infante and Jill S. Clancy. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Cancer Research, Journal of Thoracic Oncology and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.